Bedrosian Camille L — SEC insider filings

SEC reporting owner CIK 1326969. 39 insider filings on record with FilingPulse; latest filed 2026-09-14.

Transaction summary — filings shown

Covers all 39 filings on record, filed 2020-09-03 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Ultragenyx Pharmaceutical Inc. (RARE)EVP and Chief Medical Officer11—12 legs · 51,130 sh · $6,035,02514
Amylyx Pharmaceuticals, Inc. (AMLX)Chief Medical Officer12—8 legs · 64,396 sh · $798,6599
Crinetics Pharmaceuticals, Inc. (CRNX)Director8——20
RHYTHM PHARMACEUTICALS, INC. (RYTM)Director8——13

Insider filings — Bedrosian Camille L

FiledFormIssuerReported transactionsSource
2026-09-144Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 7,947 @ $32.21 · Sale (S): 2,081 @ $33.09EDGAR
2026-09-014Crinetics Pharmaceuticals, Inc. (CRNX)Disposition to issuer (D): 16,300 @ $85 · Disposition to issuer (D): 5,925 @ $85 · Disposition to issuer (D): 25,000 (derivative) @ $68.92 · Disposition to issuer (D): 17,500 (derivative) @ $64.77 · Disposition to issuer (D): 17,500 (derivative) @ $66.71 · Disposition to issuer (D): 17,500 (derivative) @ $64.68 · +3 moreEDGAR
2026-08-204Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 22,807 @ $0EDGAR
2026-06-224Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 5,925 @ $0 · Grant/award (A): 9,730 (derivative) @ $0EDGAR
2026-03-094Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 95,990 @ $0 · Grant/award (A): 143,985 (derivative) @ $0EDGAR
2026-03-044Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 6,461 @ $14.58EDGAR
2025-12-034Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 6,580 @ $14.35EDGAR
2025-10-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 12,039 @ $14.58EDGAR
2025-06-264RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 7,037 (derivative) @ $0 · Grant/award (A): 4,712 (derivative) @ $0EDGAR
2025-06-234RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2025-06-134Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 6,900 @ $0 · Grant/award (A): 10,350 (derivative) @ $0EDGAR
2025-04-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 12,425 @ $3.47EDGAR
2025-03-104Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 68,420 @ $0 · Grant/award (A): 102,630 (derivative) @ $0EDGAR
2024-12-034Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 5,421 @ $5.54EDGAR
2024-10-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 11,442 @ $3.20EDGAR
2024-06-254RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 3,000 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2024-06-204RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 14,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0EDGAR
2024-06-114Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 3,400 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2024-04-184Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 96,910 @ $0 · Grant/award (A): 120,000 (derivative) @ $0EDGAR
2023-11-294Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 58,333 @ $0 · Grant/award (A): 162,500 (derivative) @ $0EDGAR
2023-06-234RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 14,000 (derivative) @ $0 · Grant/award (A): 3,000 (derivative) @ $0EDGAR
2023-06-214Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 6,000 @ $0 · Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-03-034Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 2,663 @ $0 · Sale (S): 3,881 @ $45.25EDGAR
2022-06-214Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2022-06-104RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-03-034Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 2,821 @ $66.62 · Grant/award (A): 14,000 @ $0 · Grant/award (A): 24,900 (derivative) @ $0EDGAR
2022-02-014Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 1,657 @ $66.30EDGAR
2021-10-184Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 359 @ $81.14EDGAR
2021-09-024Ultragenyx Pharmaceutical Inc. (RARE)Option exercise (M): 2,500 @ $55 · Sale (S): 2,500 @ $100.03 · Option exercise (M): 2,500 @ $55 · Sale (S): 2,500 @ $100.18 · Option exercise (M): 2,500 (derivative) @ $0 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2021-06-234Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2021-06-114RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-05-104Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 364 @ $113.67EDGAR
2021-04-194Ultragenyx Pharmaceutical Inc. (RARE)Option exercise (M): 5,000 @ $55 · Sale (S): 5,000 @ $109.09 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2021-03-034Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 5,500 @ $0 · Grant/award (A): 4,636 @ $0 · Sale (S): 4,543 @ $138.18 · Grant/award (A): 11,000 (derivative) @ $0EDGAR
2021-02-024Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 2,243 @ $140.36EDGAR
2021-01-194Ultragenyx Pharmaceutical Inc. (RARE)Option exercise (M): 25,000 @ $55 · Sale (S): 25,000 @ $139.18 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2020-12-114RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 37,000 (derivative) @ $0EDGAR
2020-10-164Ultragenyx Pharmaceutical Inc. (RARE)Sale (S): 262 @ $88EDGAR
2020-09-034Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 25,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-03 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1326969 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs